LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
1.725
-0.045 (-2.54%)
At close: Apr 9, 2025, 4:00 PM
1.800
+0.075 (4.35%)
After-hours: Apr 9, 2025, 4:14 PM EDT
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $32.91 million as of April 9, 2025. Its market cap has decreased by -72.48% in one year.
Market Cap
32.91M
Enterprise Value
57.58M
1-Year Change
-72.48%
Ranking
Category
Stock Price
1.73
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $32.91M, a decrease of -85.55%. That is a compound annual growth rate of -40.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2025 | 33.77M | -48.84% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.12B |
| UnitedHealth Group | 507.89B |
| Johnson & Johnson | 363.48B |
| AbbVie | 317.67B |
| Novo Nordisk | 281.88B |
| Abbott Laboratories | 215.34B |
| Merck & Co. | 200.93B |
| AstraZeneca | 198.58B |